InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Downs Christopher, Chief Financial Officer. Insider active across 1 companies, notably CNS Pharmaceuticals, Inc.. Aggregated, 5 filings have been logged. Total volume traded: €17k. The latest transaction was disclosed on 11 March 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
Declarations5 total
€9,28833,000 shares@ €0.28150.23% mcap34.7% of flow
Common Stock
SEC:0001683168-22-001631:0·
€4,1595,000 shares@ €0.831847.7% of flow
Common Stock
SEC:0001683168-21-006141·
Ideal exit: 2 Sept 2022 (T+270)
€4,1595,000 shares@ €0.83180.10% mcap15.6% of flow
Common Stock
SEC:0001683168-21-006141:0·
Ideal exit: 2 Sept 2022 (T+270)
€4,5674,500 shares@ €1.014852.3% of flow
Common Stock
SEC:0001683168-21-005869·
Ideal exit: 16 Aug 2022 (T+270)
€4,5674,500 shares@ €1.01480.11% mcap17.1% of flow
Common Stock
SEC:0001683168-21-005869:0·
Ideal exit: 16 Aug 2022 (T+270)
5 of 5 declarations
About Downs Christopher
Christopher Downs is the Chief Financial Officer of CNS Pharmaceuticals, Inc. He is responsible for the financial management of the company, overseeing financial operations and strategic planning. Christopher plays a key role in optimizing financial performance and achieving CNS Pharmaceuticals' growth objectives.
